Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

View:
Post by AlfredSisley on Apr 06, 2021 8:19am

PROTHENA?

Whether an agreement was reached or not, would think this is material and merits an update, it's been almost 1 week since end of March.

Thoughts?
Comment by greaterfoolFred on Apr 06, 2021 10:17am
There might be an announcement in the future, since I don't think that we are going to walk away because Prothena are late making a decision.  But if they have walked away from us, we will probably have to wait for prophet to deduce it from some footnote in someone's company report.
Comment by JDavenport on Apr 06, 2021 12:10pm
There were no public announcements made about the previous three Prothena option target extensions. They were evenutally detailed weeks or months later in finacial reports. I wasn't expecting a public update about the latest extension, if there was one. I wrote in depth about the Prothena/XOMA situations here. jd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities